The idea for Splay, a unique device perfect for a mobile workforce, was born on the Rice University campus. Images courtesy

A Houston company born out of Rice University has crowdfunded its way into the manufacturing phase of its startup journey.

Arovia, founded by Alex Wesley and George Zhu, has a product that solves some major obstacles people on the go face as they work — or entertain — from home, a hotel, coffee shop, etc. Splay is a unique collapsable, portable device that doubles as both a display and projector.

The founders first launched their product in 2016 and raised over $700,000 from backers on their crowdfunding campaign. After raising investment funding, including an investment from the Texas Halo Fund, Wesley and Zhu recently returned to their crowdfunding roots and ran a 30-day pre-order campaign on Kickstarter during which they sold over $300,000 worth of product.

“We couldn't have made Splay without the Houston Startup Community," Wesley says.

Wesley was an MBA student when he met Zhu, who was working towards a B.S. in Mechanical Engineering, after posting a job description in search of a co-founder, a requirement of the Owlspark program.

“Owlspark accepted the business idea, with the stipulation that I needed to find a co-founder,” says Wesley. “I sent out a job description, and a big part of the application process was to provide ideas for making this crazy idea work. I sent the job description at around 9 pm and received an email from George at around 1 am with an extremely detailed proposal. That was the start; and since then, we’ve basically been like brothers — I’ve even lived with him and his parents in China.”

Wesley credits Owlspark as an important part of their formation, beyond the impetus for their partnership.

“It was a great experience for us. The focus on customer interviews is something that is very easy to avoid, but it’s extremely important. You don’t have a product if nobody wants to buy it — you don’t have a company without customers," Wesley says. "During our time at Owlspark, we did over 100 customer interviews, which gave a lot of insight into the viability of the idea and who it would be useful for. We still utilize many of those insights today.”

But Owlspark wasn’t the only accelerator program that Wesley and Zhu joined. They also participated in Hax, a top hardware-focused accelerator, and Luminate, a top optics-focused accelerator. They also competed in the Rice Business Plan Competition, which Wesley says helped them refine their pitch which ultimately secured their funding.

“We pitched at angel groups including the Houston Angel Network and their fund The Halo Fund, Keiretsu Forum and their fund Keiretsu Capital, Rochester Angel Network, and the GOOSE Society. We also won the Texas A&M New Venture Competition,” says Wesley.

With this financial backing, Arovia received the necessary support for the R&D phase for Splay, taking the product into its manufacturing process and pre-sale campaign.

“Yes, it went very well,” shares Wesley, adding that they are still looking for support on the Indiegogo campaign. “Now we are focusing on pre-selling in other markets, like Japan."

Splay can be used as a portable screen, or the projector can be removed to be used on its own. Photo via Splay

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston geothermal unicorn Fervo officially files for IPO

going public

Fervo Energy has officially filed for IPO.

The Houston-based geothermal unicorn filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission on April 17 to list its Class A common stock on the Nasdaq exchange. Fervo intends to be listed under the ticker symbol "FRVO."

The number and price of the shares have not yet been determined, according to a news release from Fervo. J.P. Morgan, BofA Securities, RBC Capital Markets and Barclays are leading the offering.

The highly anticipated filing comes as Fervo readies its flagship Cape Station geothermal project to deliver its first power later this year

"Today, miles-long lines for gasoline have been replaced by lines for electricity. Tech companies compete for megawatts to claim AI market share. Manufacturers jockey for power to strengthen American industry. Utilities demand clean, firm electricity to stabilize the grid," Fervo CEO Tim Latimer shared in the filing. "Fervo is prepared to serve all of these customers. Not with complex, idiosyncratic projects but with a simplified, standardized product capable of delivering around-the-clock, carbon-free power using proven oil and gas technology."

Fervo has been preparing to file for IPO for months. Axios Pro first reported that the company "quietly" filed for an IPO in January and estimated it would be valued between $2 billion and $3 billion.

Fervo also closed $421 million in non-recourse debt financing for the first phase of Cape Station last month and raised a $462 million Series E in December. The company also announced the addition of four heavyweights to its board of directors last week, including Meg Whitman, former CEO of eBay, Hewlett-Packard, and Spring-based HPE.

Fervo reported a net loss of $70.5 million for the 2025 fiscal year in the S-1 filing and a loss of $41.1 million in 2024.

Tracxn.com estimates that Fervo has raised $1.12 billion over 12 funding rounds. The company was founded in 2017 by Latimer and CTO Jack Norbeck.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

New UT Austin med center, anchored by MD Anderson, gets $1 billion gift

Future of Health

A donation announced Tuesday, April 21, breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release.

The release also records "significant support" for undergraduate scholarships, student housing, and the Texas Advanced Computing Center for supercomputing research.

Both the new research campus and the UT Dell Medical Center will integrate advanced computing into their research and practices. At the medical center, the university hopes that will lead to "earlier detection, more precise and personalized care, and better health outcomes." The University of Texas MD Anderson Cancer Center will also be integrated into the new medical center.

That comes with a numeric goal measured in 10s: raise $10 billion and rank among the top 10 medical centers in the U.S., both in the next decade.

In the shorter term, the university will break ground on the medical center with architecture firm Skidmore, Owings & Merrill (SOM) "later this year."

“UT Austin, where Dell Technologies was founded from a dorm room, has always been a place where bold ideas become real-world impact,” said Michael and Susan Dell in a joint statement.

They continued, “What makes this moment so meaningful is the opportunity to build something that brings every part of the journey together — from how students learn, to how discoveries are made, to how care reaches families. By bringing together medicine, science and computing in one campus designed for the AI era, UT can create more opportunity, deliver better outcomes, and build a stronger future for communities across Texas and beyond.”

This is the second major gift this year for the planned multibillion-dollar medical center. In January, Tench Coxe, a former venture capitalist who’s a major shareholder in chipmaking giant Nvidia, and Simone Coxe, co-founder and former CEO of the Blanc & Otus PR firm, contributed $100 million$100 million.

Baylor scientist lands $2M grant to explore links between viruses and Alzheimer’s

Alzheimer’s research

A Baylor College of Medicine scientist will begin exploring the possible link between Alzheimer’s disease and viral infections thanks to a $2 million grant awarded in March.

Dr. Ryan S. Dhindsa is an assistant professor of pathology & immunology at Baylor and a principal investigator at Texas Children’s Duncan Neurological Research Institute (Duncan NRI). He hypothesizes that Alzheimer’s may have some link to previous viral infections contracted by the patient. To study this intriguing possibility, the American Brain Foundation has gifted him the Cure One, Cure Many award in neuroinflammation.

“It is an honor to receive this support from the Cure One, Cure Many Award. Viral infections are emerging as a major, underappreciated driver of Alzheimer's disease, and this award will allow our team to conduct the most comprehensive screen of viral exposures and host genetics in Alzheimer's to date, spanning over a million individuals,” Dhindsa said in a news release. “Our goal is to identify which viruses matter most, why some people are more vulnerable than others, and ultimately move the field closer to new therapeutic strategies for patients.”

Roughly 150 million people worldwide will suffer from Alzheimer’s by 2050, making it the most common cause of dementia in the world. Despite this, scientists are still at a loss as to what exactly causes it.

Dhindsa’s research is part of a new range of theories that certain viral infections may trigger Alzheimer’s. His team will take a two-fold approach. First, they will analyze the medical records of more than a million individuals looking for patterns. Second, they will analyze viral DNA in stem cell-derived brain cells to see how the infections could contribute to neurological decay. The scale of the genomic data gathering is unprecedented and may highlight a link that traditional studies have missed.

Also joining the project are Dr. Caleb Lareau of Memorial Sloan Kettering Cancer Center and Dr. Artem Babaian of the University of Toronto. Should a link be found, it would open the door to using anti-virals to prevent or treat Alzheimer’s.